Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1992 Jan;33(1):33–38. doi: 10.1111/j.1365-2125.1992.tb03997.x

Gastrointestinal blood loss after non-steroidal anti-inflammatory drugs. Measurement by selective determination of faecal porphyrins.

A Cohen 1, J K Boeijinga 1, P M van Haard 1, R C Schoemaker 1, A van Vliet-Verbeek 1
PMCID: PMC1381196  PMID: 1540488

Abstract

1. A method for the detection of gastrointestinal blood loss based upon the selective measurement of faecal porphyrins was tested in two studies in healthy volunteers. 2. In the first study subjects (n = 6) received intragastric autologous blood (saline, 2 and 6 ml as a single dose) resulting in a dose dependent increase in faecal porphyrins. 3. In a subsequent placebo controlled cross over study in 12 subjects acetylsalicylic acid (ASA), nabumetone (a new NSAID) or placebo were administered for 5 days with a washout period of 9 days. They were no dietary restrictions. 4. All faeces were collected during the treatment period and both the full faecal homogenate and a random faecal sample were analyzed for deutero- and pemptoporphyrin content by h.p.l.c. Additionally a benzidine reaction was performed. 5. There was a highly significant correlation (r = 0.95) between the values obtained from random samples and the full homogenate. ASA increased the faecal porphyrin excretion (P less than 0.001) compared with placebo in contrast to nabumetone. Complaints of dyspepsia were most common after ASA. 6. Measurement of faecal porphyrins is useful for monitoring NSAID induced upper gastrointestinal blood loss and lacks some of the practical constraints of other methods.

Full text

PDF
37

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlquist D. A., McGill D. B., Schwartz S., Taylor W. F., Owen R. A. Fecal blood levels in health and disease. A study using HemoQuant. N Engl J Med. 1985 May 30;312(22):1422–1428. doi: 10.1056/NEJM198505303122204. [DOI] [PubMed] [Google Scholar]
  2. Beukeveld G. J., Wolthers B. G., van Saene J. J., de Haan T. H., de Ruyter-Buitenhuis L. W., van Saene R. H. Patterns of porphyrin excretion in feces as determined by liquid chromatography; reference values and the effect of flora suppression. Clin Chem. 1987 Dec;33(12):2164–2170. [PubMed] [Google Scholar]
  3. Bjarnason I., Williams P., So A., Zanelli G. D., Levi A. J., Gumpel J. M., Peters T. J., Ansell B. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet. 1984 Nov 24;2(8413):1171–1174. doi: 10.1016/s0140-6736(84)92739-9. [DOI] [PubMed] [Google Scholar]
  4. Carson J. L., Strom B. L. The gastrointestinal side effects of the nonsteroidal anti-inflammatory drugs. J Clin Pharmacol. 1988 Jun;28(6):554–559. doi: 10.1002/j.1552-4604.1988.tb03175.x. [DOI] [PubMed] [Google Scholar]
  5. Caruso I., Bianchi Porro G. Gastroscopic evaluation of anti-inflammatory agents. Br Med J. 1980 Jan 12;280(6207):75–78. doi: 10.1136/bmj.280.6207.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Friedel H. A., Todd P. A. Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases. Drugs. 1988 May;35(5):504–524. doi: 10.2165/00003495-198835050-00002. [DOI] [PubMed] [Google Scholar]
  7. Frommer D. J., Kapparis A., Brown M. K. Improved screening for colorectal cancer by immunological detection of occult blood. Br Med J (Clin Res Ed) 1988 Apr 16;296(6629):1092–1094. doi: 10.1136/bmj.296.6629.1092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goldschmiedt M., Ahlquist D. A., Wieand H. S., McGill D. B., Taylor W. F., Ellefson R. D. Measurement of degraded fecal hemoglobin-heme to estimate gastrointestinal site of occult bleeding. Appraisal of its clinical utility. Dig Dis Sci. 1988 May;33(5):605–608. doi: 10.1007/BF01798364. [DOI] [PubMed] [Google Scholar]
  9. Henry D. A., Johnston A., Dobson A., Duggan J. Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids. Br Med J (Clin Res Ed) 1987 Nov 14;295(6608):1227–1229. doi: 10.1136/bmj.295.6608.1227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hunt J. N. A procedure for measuring gastric bleeding caused by drugs. Dig Dis Sci. 1979 Jul;24(7):525–528. doi: 10.1007/BF01489320. [DOI] [PubMed] [Google Scholar]
  11. Lanza F. L., Royer G. L., Jr, Nelson R. S., Chen T. T., Seckman C. E., Rack M. F. The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers: a gastroscopic and photographic study. Dig Dis Sci. 1979 Nov;24(11):823–828. doi: 10.1007/BF01324896. [DOI] [PubMed] [Google Scholar]
  12. Lanza F., Peace K., Gustitus L., Rack M. F., Dickson B. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration. Am J Gastroenterol. 1988 Feb;83(2):143–146. [PubMed] [Google Scholar]
  13. Lussier A., Davis A., Lussier Y., Lebel E. Comparative gastrointestinal blood loss associated with placebo, aspirin, and nabumetone as assessed by radiochromium (51Cr). J Clin Pharmacol. 1989 Mar;29(3):225–229. doi: 10.1002/j.1552-4604.1989.tb03317.x. [DOI] [PubMed] [Google Scholar]
  14. Prichard P. J., Kitchingman G. K., Walt R. P., Daneshmend T. K., Hawkey C. J. Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin. BMJ. 1989 Feb 25;298(6672):493–496. doi: 10.1136/bmj.298.6672.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Prichard P. J., Poniatowska T. J., Willars J. E., Ravenscroft A. T., Hawkey C. J. Effect in man of aspirin, standard indomethacin, and sustained release indomethacin preparations on gastric bleeding. Br J Clin Pharmacol. 1988 Aug;26(2):167–172. doi: 10.1111/j.1365-2125.1988.tb03382.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ryan J. R., Riley W. A., Vargas R., Offen W. W., Gruber C. M. Enteric coating of fenoprofen calcium reduces gastrointestinal microbleeding. Clin Pharmacol Ther. 1987 Jul;42(1):28–32. doi: 10.1038/clpt.1987.103. [DOI] [PubMed] [Google Scholar]
  17. Silvoso G. R., Ivey K. J., Butt J. H., Lockard O. O., Holt S. D., Sisk C., Baskin W. N., Mackercher P. A., Hewett J. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med. 1979 Oct;91(4):517–520. doi: 10.7326/0003-4819-91-4-517. [DOI] [PubMed] [Google Scholar]
  18. Somerville K., Faulkner G., Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet. 1986 Mar 1;1(8479):462–464. doi: 10.1016/s0140-6736(86)92927-2. [DOI] [PubMed] [Google Scholar]
  19. Standefer J. C., Vanderjagt D. Use of tetramethylbenzidine in plasma hemoglobin assay. Clin Chem. 1977;23(4):749–751. [PubMed] [Google Scholar]
  20. Wilson J. H., Koole-Lesuis H., Edixhoven-Bosdijk A., van den Berg J. W., van Essen H. A. Determination of haemoglobin in gastric aspirates. J Clin Chem Clin Biochem. 1985 Dec;23(12):841–844. doi: 10.1515/cclm.1985.23.12.841. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES